Literature DB >> 16751419

CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice.

Sarah L Hayward1, Norma Bautista-Lopez, Kunimasa Suzuki, Alexey Atrazhev, Peter Dickie, John F Elliott.   

Abstract

In humans, spontaneous autoimmune attack against cardiomyocytes often leads to idiopathic dilated cardiomyopathy (IDCM) and life-threatening heart failure. HLA-DQ8 transgenic IAb knockout NOD mice (NOD.DQ8/Ab(0); DQA1*0301, DQB1*0302) develop spontaneous anticardiomyocyte autoimmunity with pathology very similar to human IDCM, but why the heart is targeted is unknown. In the present study, we first investigated whether NOD/Ab(0) mice transgenic for a different DQ allele, DQ6, (DQA1*0102, DQB1*0602) would also develop myocarditis. NOD.DQ6/Ab(0) animals showed no cardiac pathology, implying that DQ8 is specifically required for the myocarditis phenotype. To further characterize the cellular immune mechanisms, we established crosses of our NOD.DQ8/Ab(0) animals with Rag1 knockout (Rag1(0)), Ig H chain knockout (IgH(0)), and beta(2)-microglobulin knockout (beta(2)m(0)) lines. Adoptive transfer of purified CD4 T cells from NOD.DQ8/Ab(0) mice with complete heart block (an indication of advanced myocarditis) into younger NOD.DQ8/Ab(0) Rag1(0) animals induced cardiac pathology in all recipients, whereas adoptive transfer of purified CD8 T cells or B lymphocytes had no effect. Despite the absence of B lymphocytes, NOD.DQ8/Ab(0)IgH(0) animals still developed complete heart block, whereas NOD.DQ8/Ab(0)beta(2)m(0) mice (which lack CD8 T cells) failed to develop any cardiac pathology. CD8 T cells (and possibly NK cells) seem to be necessary to initiate disease, whereas once initiated, CD4 T cells alone can orchestrate the cardiac pathology, likely through their capacity to recruit and activate macrophages. Understanding the cellular immune mechanisms causing spontaneous myocarditis/IDCM in this relevant animal model will facilitate the development and testing of new therapies for this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751419     DOI: 10.4049/jimmunol.176.12.7715

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.

Authors:  Tobias L Freitag; Joseph R Podojil; Ryan M Pearson; Frank J Fokta; Cecilia Sahl; Marcel Messing; Leif C Andersson; Katarzyna Leskinen; Päivi Saavalainen; Lisa I Hoover; Kelly Huang; Deborah Phippard; Sanaz Maleki; Nicholas J C King; Lonnie D Shea; Stephen D Miller; Seppo K Meri; Daniel R Getts
Journal:  Gastroenterology       Date:  2020-02-04       Impact factor: 22.682

2.  Myocarditis: a defect in central immune tolerance?

Authors:  Todd C Metzger; Mark S Anderson
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

3.  Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans.

Authors:  Huijuan Lv; Evis Havari; Sheena Pinto; Raju V S R K Gottumukkala; Lizbeth Cornivelli; Khadir Raddassi; Takashi Matsui; Anthony Rosenzweig; Roderick T Bronson; Ross Smith; Anne L Fletcher; Shannon J Turley; Kai Wucherpfennig; Bruno Kyewski; Myra A Lipes
Journal:  J Clin Invest       Date:  2011-03-23       Impact factor: 14.808

4.  The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis.

Authors:  Zoran V Popovic; Shijun Wang; Maria Papatriantafyllou; Ziya Kaya; Stefan Porubsky; Maria Meisner; Mahnaz Bonrouhi; Sven Burgdorf; Marian F Young; Liliana Schaefer; Hermann-Josef Gröne
Journal:  J Immunol       Date:  2011-11-16       Impact factor: 5.422

5.  Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells.

Authors:  S M Büchner; K Sliva; H Bonig; I Völker; Z Waibler; J Kirberg; B S Schnierle
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

6.  Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Authors:  Julie A Lucas; Julia Menke; Whitney A Rabacal; Frederick J Schoen; Arlene H Sharpe; Vicki R Kelley
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

7.  Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice.

Authors:  Veena Taneja; Chella S David
Journal:  J Autoimmun       Date:  2009-10-07       Impact factor: 7.094

8.  FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.

Authors:  Ferenc Boldizsar; Oktavia Tarjanyi; Katalin Olasz; Akos Hegyi; Katalin Mikecz; Tibor T Glant; Tibor A Rauch
Journal:  Cardiovasc Pathol       Date:  2016-05-17       Impact factor: 2.185

9.  Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens.

Authors:  Venkataswarup Tiriveedhi; Masashi Takenaka; Nayan J Sarma; Andrew G Gelman; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2013-05-02       Impact factor: 10.247

Review 10.  Myocarditis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.